Loading…
Loading…
688837.SS (Evopoint Biosciences Co. Ltd.) is a recent IPO.
It began trading on September 16, 2026, giving it a few months of public history. Many charts and metrics below are sparse or empty until more price, financial, and analyst history accumulates. The affected sections are flagged individually so you can tell limited history from missing data.

| 688331.SS688331.SSRemeGen Co. Ltd. Class A | RemeGen Co. Ltd. Class A | ¥101.17 | ¥56.7B |
| 688578.SS688578.SSShanghai Allist Pharmaceuticals Co., Ltd. | Shanghai Allist Pharmaceuticals Co., Ltd. | ¥88.12 | ¥39.7B |
| 300558.SZ300558.SZBetta Pharmaceuticals Co., Ltd. | Betta Pharmaceuticals Co., Ltd. | ¥42.63 | ¥18.0B |
| 688321.SS688321.SSShenzhen Chipscreen Biosciences Co., Ltd. | Shenzhen Chipscreen Biosciences Co., Ltd. | ¥22.68 | ¥10.0B |
| 300204.SZ300204.SZStaidson (Beijing) BioPharmaceuticals Co., Ltd. | Staidson (Beijing) BioPharmaceuticals Co., Ltd. | ¥18.07 | ¥9.8B |
| 688513.SS688513.SSChengdu Easton Biopharmaceuticals Co., Ltd. | Chengdu Easton Biopharmaceuticals Co., Ltd. | ¥46.28 | ¥8.2B |
| 688176.SS688176.SSJiangsu Yahong Meditech Co Ltd | Jiangsu Yahong Meditech Co Ltd | ¥12.03 | ¥6.9B |
| 688136.SS688136.SSKexing Biopharm Co., Ltd. | Kexing Biopharm Co., Ltd. | ¥20.30 | ¥4.0B |